文献速递中枢神经肿瘤放疗放疗物理与技术

功能性脑成像干预用于胶质母细胞瘤患者放射治疗计划:一项系统综述

Functional brain imaging interventions for radiation therapy planning in patients with glioblastoma: a systematic review.
PubMed 文献 · Radiat Oncol · 2022-11-12

本系统综述旨在综合在胶质母细胞瘤患者放疗计划中整合功能生物标志物的不同策略的结果,以支持临床医生和进一步研究。共筛选5733条引文,53条引文(32项研究)符合标准。分析表明,与历史对照组相比,中位总生存期改善超过两个月;同步整合推量72-76 Gy分30次,当采用逆向计划递送至小于100 cm³的体积时,似乎具有可接受的毒性特征。不同研究组实施功能图像引导放疗的方法存在显著异质性。

要点

  • 共纳入32项研究,功能图像引导放疗方法异质性显著。
  • 与历史对照组相比,中位总生存期改善超过两个月。
  • 同步整合推量72-76 Gy分30次,递送至小于100 cm³体积时毒性似乎可接受。

核心结论

  • 不同研究组实施功能图像引导放疗的方法存在显著异质性。
  • 推荐在胶质母细胞瘤患者放疗计划设计时,将功能成像数据整合至大体肿瘤体积,并使用适当技术特异性 margins 创建临床靶体积。

研究设计与样本

  • 系统综述,方案注册于PROSPERO(CRD42021221021),遵循PRISMA指南进行结构化检索,使用Newcastle-Ottawa量表进行质量评估,使用Covidence提取研究特征、干预方法和结果。
  • 共筛选5733条引文,53条引文(n=32项研究)符合综述标准。

主要发现

  • 研究比较了标准放疗计划体积与功能图像衍生体积(n=20项研究)、治疗放疗体积与复发(n=15项研究)、对当前标准靶区勾画的影响(n=9项研究)、治疗功能体积与生存(n=8项研究)、功能引导剂量递增(n=8项研究)、放射组学(n=4项研究)以及最佳危及器官保护(n=3项研究)。
  • 靶区勾画和剂量递增的方法存在异质性。
  • 分析表明,与历史对照组相比,中位总生存期改善超过两个月。
  • 同步整合推量剂量递增72-76 Gy分30次,当采用逆向计划递送至小于100 cm³的体积时,似乎具有可接受的毒性特征。

关键数值与推荐

  • 推荐将功能成像数据整合至大体肿瘤体积,并使用适当技术特异性 margins 创建临床靶体积。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 不同研究组实施功能图像引导放疗的方法存在显著异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: This systematic review aims to synthesise the outcomes of different strategies of incorporating functional biological markers in the radiation therapy plans of patients with glioblastoma to support clinicians and further research. METHODS: The systematic review protocol was registered on PROSPERO (CRD42021221021). A structured search for publications was performed following PRISMA guidelines. Quality assessment was performed using the Newcastle-Ottawa Scale. Study characteristics, intervention methodology and outcomes were extracted using Covidence. Data analysis focused on radiation therapy target volumes, toxicity, dose distributions, recurrence and survival mapped to functional image-guided radiotherapy interventions. RESULTS: There were 5733 citations screened, with 53 citations (n = 32 studies) meeting review criteria. Studies compared standard radiation therapy planning volumes with functional image-derived volumes (n = 20 studies), treated radiation therapy volumes with recurrences (n = 15 studies), the impact on current standard target delineations (n = 9 studies), treated functional volumes and survival (n = 8 studies), functionally guided dose escalation (n = 8 studies), radiomics (n = 4 studies) and optimal organ at risk sparing (n = 3 studies). The approaches to target outlining and dose escalation were heterogeneous. The analysis indicated an improvement in median overall survival of over two months compared with a historical control group. Simultaneous-integrated-boost dose escalation of 72-76 Gy in 30 fractions appeared to have an acceptable toxicity profile when delivered with inverse planning to a volume smaller than 100 cm[Formula: see text]. CONCLUSION: There was significant heterogeneity between the approaches taken by different study groups when implementing functional image-guided radiotherapy. It is recommended that functional imaging data be incorporated into the gross tumour volume with appropriate technology-specific margins used to create the clinical target volume when designing radiation therapy plans for patients with glioblastoma.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Ryan JT, Nakayama M, Gleeson I, et al. Functional brain imaging interventions for radiation therapy planning in patients with glioblastoma: a systematic review. Radiat Oncol. 2022. PMID: 36371225. doi:10.1186/s13014-022-02146-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。